End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 CNY | -1.51% | +2.78% | -20.04% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- With an expected P/E ratio at 40.48 and 33.33 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.04% | 746M | - | ||
-18.90% | 16.51B | B+ | ||
+4.50% | 12.53B | B | ||
+4.81% | 11.74B | B+ | ||
+2.43% | 10.06B | B+ | ||
-4.75% | 7.57B | A- | ||
+21.11% | 7.22B | D | ||
+5.46% | 6.68B | B- | ||
+45.72% | 4.54B | - | ||
-3.49% | 4.32B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300143 Stock
- Ratings INKON Life Technology Co., Ltd.